Century Therapeutics Inc

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

IPSC$1.81+7.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

**(**In thousands, except share and per share amounts)


· · December 31, 2023 · · December 31, 2022 ·
· · ·
Assets

Current assets
Cash and cash equivalents	$47,324	$84,265
Short-term investments	125,414	231,233
Escrow deposits, current	—	220
Prepaid expenses and other current assets	4,256	4,003
Total current assets	176,994	319,721

Property and equipment, net	71,705	82,785
Operating lease right-of-use assets	20,376	28,945
Restricted cash	1,979	1,979
Long-term investments	89,096	51,854
Security deposits and non-current assets	541	1,260
Total assets	$360,691	$486,544

Liabilities and stockholders’ equity

Current liabilities
Accounts payable	$2,741	$5,454
Accrued expenses and other liabilities	10,149	9,841
Deposit liability	584	866
Long-term debt, current	—	6,502
Deferred revenue, current	4,372	7,154
Total current liabilities	17,846	29,817

Operating lease liability, long term	46,658	38,698
Deposit liability, non-current	56	718
Deferred revenue, non-current	111,381	110,834
Long-term debt, net	—	3,739

Total liabilities	175,941	183,806

Commitments and contingencies (Note 10)
Stockholders' equity:
Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at December 31, 2023 and December 31, 2022	—	—
Common stock, $0.0001 par value, 125,236,190 shares authorized; 60,335,701 and 58,473,660 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	6	6
Additional paid-in capital	840,407	824,292
Accumulated deficit	(655,771)	(519,098)
Accumulated other comprehensive income (loss)	108	(2,462)
Total stockholders’ equity	184,750	302,738
Total liabilities and stockholders’ equity	$360,691	$486,544

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.